Fish /

Atlantic Salmon (Salmo salar)

97 adverse event reports submitted to the FDA

Important: Adverse event reports are voluntarily submitted and do not prove causation. Consult your veterinarian for medical decisions about your fish.
97
Total Reports
96
Deaths Reported
9900.0%
Death Rate
0.7 yr
Avg Age at Report
Average weight at time of report: 0.4 kg (0.9 lbs)

Top Reported Reactions

Death 69
IGA Animal mortality greater than expected 41
Fish body deformity 31
Moribund 24
IGA Animal morbidity greater than expected 17
Death by euthanasia 14
Unrelated death 1
Partial lack of efficacy 1
Product Defect, General 1
Genotypic test failure (IGA) 1
Fungal skin infection NOS 1
Containment system or component failure (IGA) 1
Fish malformation 1

Most Referenced Drugs

Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) 88
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage 7
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A Locus In The Eo-1A Lineage) 1
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The Alocus In The Eo-1A Lineage) 1

Outcome Breakdown

Died
69 (60.0%)
Euthanized
42 (36.5%)
Ongoing
4 (3.5%)

Gender Distribution

Female 93 (95.9%)
Unknown 4 (4.1%)

Reports by Year

Year Reports Trend
2015 2
2016 16
2017 12
2018 7
2019 10
2020 16
2021 14
2022 9
2023 10
2024 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Rank #232 by report volume. Data reflects voluntary submissions and may not represent actual incidence rates.